Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
RESEARCH TOOLSreports
Holding RNAZ?
Track your performance easily
TransCode Therapeutics (RNAZ) Ownership Overview
0.73%
Insiders
0.22% Mutual Funds
0.76% Other Institutional Investors
98.30% Public Companies and
Individual Investors
The ownership structure of TransCode Therapeutics (RNAZ) stock is a mix of institutional, retail, and individual investors. , 0.73% is owned by Insiders, and 98.30% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 112,077 | Insider | 0.40% | 43,038 | |
| 56,318 | Insider | 0.33% | 21,626 | |
| 37,804 | Institution | 0.22% | 14,517 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 37,804 | Institution | 0.22% | 14,517 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns TransCode Therapeutics (RNAZ)?
According to the latest TipRanks data, approximately 0.76% of the company's stock is held by institutional investors, 0.73% is held by insiders, and 98.30% is held by retail investors.
What percentage of TransCode Therapeutics (RNAZ) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.76% of TransCode Therapeutics (RNAZ) stock is held by institutional investors.
What percentage of TransCode Therapeutics (RNAZ) stock is held by retail investors?
According to the latest TipRanks data, approximately 98.30% of TransCode Therapeutics (RNAZ) stock is held by retail investors.
Who owns the most shares of TransCode Therapeutics (RNAZ)?
Medarova Zdravka owns the most shares of TransCode Therapeutics (RNAZ).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.